185 related articles for article (PubMed ID: 19218909)
21. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
22. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
Kruper LL; Spitz FR; Czerniecki BJ; Fraker DL; Blackwood-Chirchir A; Ming ME; Elder DE; Elenitsas R; Guerry D; Gimotty PA
Cancer; 2006 Nov; 107(10):2436-45. PubMed ID: 17058288
[TBL] [Abstract][Full Text] [Related]
23. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
24. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy status is a key parameter to stratify the prognostic heterogeneity of malignant melanoma in high-risk tumors >4.0 mm.
Göppner D; Ulrich J; Pokrywka A; Peters B; Gollnick H; Leverkus M
Dermatology; 2011 Feb; 222(1):59-66. PubMed ID: 21196701
[TBL] [Abstract][Full Text] [Related]
26. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
Rangel J; Torabian S; Shaikh L; Nosrati M; Baehner FL; Haqq C; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
J Clin Oncol; 2006 Oct; 24(28):4565-9. PubMed ID: 17008696
[TBL] [Abstract][Full Text] [Related]
28. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
30. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
[TBL] [Abstract][Full Text] [Related]
31. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.
Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R
Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539
[TBL] [Abstract][Full Text] [Related]
34. [Tumour regression is not predictive for higher risk of sentinel node involvement in thin melanomas (Breslow thickness < or = 1 mm)].
Kramkimel N; Maubec E; Boitier F; Cavalcanti A; Beldi M; Mamelle G; Kolb F; Duvillard P; Avril MF
Ann Dermatol Venereol; 2010 Apr; 137(4):276-80. PubMed ID: 20417360
[TBL] [Abstract][Full Text] [Related]
35. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
36. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
[TBL] [Abstract][Full Text] [Related]
37. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy.
Homolak D; Vucetić B; Puljiz Z; Blajć I; Vurnek Zivković M; Situm M
Coll Antropol; 2008 Oct; 32 Suppl 2():57-60. PubMed ID: 19138008
[TBL] [Abstract][Full Text] [Related]
38. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
Testori A; De Salvo GL; Montesco MC; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Soteldo J; Casara D; Schiavon M; Vecchiato A; Pasquali S; Baldini F; Mazzarol G; Rossi CR;
Ann Surg Oncol; 2009 Jul; 16(7):2018-27. PubMed ID: 19132446
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.
Morris KT; Busam KJ; Bero S; Patel A; Brady MS
Ann Surg Oncol; 2008 Jan; 15(1):316-22. PubMed ID: 18004626
[TBL] [Abstract][Full Text] [Related]
40. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.
Creager AJ; Shiver SA; Shen P; Geisinger KR; Levine EA
Cancer; 2002 Jun; 94(11):3016-22. PubMed ID: 12115392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
